REFERENCES
- Carmeliet P. and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407: 249–257 (2000)
- Dobrenis K., Makman M.H. and Stefano G.B. Occurrence of the opiate alkaloid-selective 3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Research 686: 239–248 (1995)
- Gille et al. Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). The Journal of Biological Chemistry 276 (5): 3222-3230 (2001)
- Gupta et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research 62: 4491-4498 (2002)
- Harrison L.M., Kastin A.J. and Zadina J.E. Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates. Peptides 19 (9): 1603–1630 (1998)
- Kolch Walter. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351: 289–305 (2000)
- Law P-Y., Wong Y.H. and Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40: 389–430 (2000)
- Lodish H., Baltimore D., Berk A., Zipursky S.L., Matsudaira P. and Darnell J.Molecular Cell Biology, W.H. Freeman and company, 4th edition (2000)
- Papapetropoulos A., Garcia-Cardeña G., Madri J.A. and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100 (12): 3131-3139 (1997)
- Parenti et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postc-apillary endothelium. The Journal of Biological Biochemistry 273 (7): 4220-4226 (1998)
- Rosen Lee S. Clinical experience with angiogenesis signaling inhibitors: Focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 9 (2): 36–44 (2002)
- Schmidt H. et al. Involvement of mitogen-activated protein kinasein agonist-induced phosphorylation of the ?-opioid receptor in HEK 293 cells. Journal of Neurochemistry 74 (1): 414-422 (2000)
- Schmidt H., Kirkpatrick J., Kamp G., Wegener G. and Peters K. Angiogenesis as a pharmalogical target. G.I.T. Laboratory Journal 5 (2001)
- Stefano G.B. et al. Presence of the ?3 opiate receptor in endothelial cells. The Journal of Biological Chemistry 270 (51): 30290-30293 (1995)
- Yu Y. and Sato J.D. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular en-dothelial growth factor. Journal of Cellular Physiology 178: 235–246 (1999)
- Zhang et al. Role for G-protein-coupled receptor kinase in agonist-specific regulation of u-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95: 7157-7162 (1998)